rs4665947
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_032604.4(ABHD1):c.114+1099T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.336 in 151,392 control chromosomes in the GnomAD database, including 9,171 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.34 ( 9167 hom., cov: 31)
Exomes 𝑓: 0.41 ( 4 hom. )
Consequence
ABHD1
NM_032604.4 intron
NM_032604.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.33
Publications
5 publications found
Genes affected
ABHD1 (HGNC:17553): (abhydrolase domain containing 1) This gene is a member of the AB hydrolase superfamily and encodes a protein with an alpha/beta hydrolase fold. This domain is common to a number of hydrolytic enzymes of widely differing phylogenetic origins and catalytic functions. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.496 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ABHD1 | NM_032604.4 | c.114+1099T>C | intron_variant | Intron 1 of 8 | ENST00000316470.9 | NP_115993.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.336 AC: 50813AN: 151260Hom.: 9140 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
50813
AN:
151260
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.412 AC: 14AN: 34Hom.: 4 Cov.: 0 AF XY: 0.318 AC XY: 7AN XY: 22 show subpopulations
GnomAD4 exome
AF:
AC:
14
AN:
34
Hom.:
Cov.:
0
AF XY:
AC XY:
7
AN XY:
22
show subpopulations
African (AFR)
AF:
AC:
1
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
AC:
0
AN:
2
South Asian (SAS)
AF:
AC:
2
AN:
2
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
11
AN:
26
Other (OTH)
AF:
AC:
0
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.433
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.336 AC: 50865AN: 151358Hom.: 9167 Cov.: 31 AF XY: 0.337 AC XY: 24871AN XY: 73900 show subpopulations
GnomAD4 genome
AF:
AC:
50865
AN:
151358
Hom.:
Cov.:
31
AF XY:
AC XY:
24871
AN XY:
73900
show subpopulations
African (AFR)
AF:
AC:
10012
AN:
41250
American (AMR)
AF:
AC:
7684
AN:
15208
Ashkenazi Jewish (ASJ)
AF:
AC:
1366
AN:
3466
East Asian (EAS)
AF:
AC:
1611
AN:
5140
South Asian (SAS)
AF:
AC:
1659
AN:
4798
European-Finnish (FIN)
AF:
AC:
2863
AN:
10402
Middle Eastern (MID)
AF:
AC:
117
AN:
292
European-Non Finnish (NFE)
AF:
AC:
24297
AN:
67794
Other (OTH)
AF:
AC:
793
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1668
3336
5005
6673
8341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
492
984
1476
1968
2460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1145
AN:
3444
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.